Monday, July 7, 2025 7/7/2025

Identifying the mycobacterial genes controlling bacteriolysis in the macrophage cytoplasm

Award Number: R21AI181133
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/17/2024
PERIOD OF PERFORMANCE END DATE: 03/31/2026

Group Awards By:

View Award Description

Identifying the mycobacterial genes controlling bacteriolysis in the macrophage cytoplasm - PROJECT SUMMARY Pathogenic mycobacteria damage the phagosome and interact with the macrophage cytoplasm. The mycobac- terial factors that control bacteriolysis in the cytoplasm are unknown. The objective of this proposal is to define the genes controlling mycobacterial bacteriolysis in the macrophage cytoplasm. The central hypothesis for this application is that mycobacteria actively control bacteriolysis in the cytoplasm. To test this hypothesis, the fol- lowing specific aims will be tested. The applicant has adapted an established reporter for cytoplasmic bacteriol- ysis from Listeria monocytogenes for use with Mycobacterium. Under the first aim, the applicant proposes a targeted approach to define the impact of known virulence factors on mycobacterial bacteriolysis. The objective of Aim 1 is to define if known virulence pathways protect M. marinum from bacteriolysis. The applicant will test the working hypothesis that known virulence pathways that modulate the inflammasome protect Mycobacterium from bacteriolysis in the macrophage cytoplasm. M. marinum strains lacking specific virulence pathways will be generated and bacteriolysis will be measured during macrophage infection. Under the second aim, the applicant proposes an unbiased approach to identify genes required for cytoplasmic adaptation of mycobacterial patho- gens. The objective of Aim 2 is to Identify genes the control mycobacterial bacteriolysis. The applicant will test working hypothesis that several conserved pathways protect mycobacterial pathogens from bacteriolysis in the cytoplasm. Two complementary genetic screens to identify molecular pathways controlling mycobacterial bacte- riolysis in the cytoplasm during macrophage infection. The applicant expects that the successful completion of Aim 1 will determine if known virulence pathways protect mycobacteria from bacteriolysis. The completion of Aim 2 is expected to identify new pathways that promote mycobacterial survival in the cytoplasm. Completion of the proposed aims will contribute an initial understanding of the mechanisms required for preventing mycobac- terial bacteriolysis in the macrophage cytoplasm, moving the field in a new direction. This contribution will be significant because it will identify a new molecular mechanism underlying mycobacterial pathogenesis. The ap- plication is conceptually innovative because it focuses on mycobacterial determinants that protect mycobacteria from bacteriolysis in the cytoplasm, which represents a shift in focus for the field. The experimental design is innovative because it applies a novel indirect reporter of cytoplasmic bacteriolysis that has not previously been used to study mycobacterial species.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $189,756 )
2025	2025	UNIVERSITY OF NOTRE DAME DU LAC	940 GRACE HALL	NOTRE DAME	IN	46556	ST JOSEPH	USA	Allergy and Infectious Diseases Research	000	2	3/17/2025	NON-COMPETING CONTINUATION	$189,756
														Subtotal = $189,756

Issue Date FY: 2024 ( Subtotal = $234,750 )
2024	2024	UNIVERSITY OF NOTRE DAME DU LAC	940 GRACE HALL	NOTRE DAME	IN	46556	ST JOSEPH	USA	Allergy and Infectious Diseases Research	001	1	9/11/2024	NEW	$23,475
2024	2024	UNIVERSITY OF NOTRE DAME DU LAC	836 GRACE HALL	NOTRE DAME	IN	46556	ST JOSEPH	USA	Allergy and Infectious Diseases Research	000	1	5/17/2024	NEW	$211,275
														Subtotal = $234,750

Grand Total All Awards = $424,506

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Identifying the mycobacterial genes controlling bacteriolysis in the macrophage cytoplasm

Award Number: R21AI181133

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/17/2024

PERIOD OF PERFORMANCE END DATE: 03/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer